Summary of Study ST002447
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001578. The data can be accessed directly via it's Project DOI: 10.21228/M8QQ79 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST002447 |
| Study Title | Bioactive molecule(s) of gut bacteria of Crocodile (Crocodylus palustris) as potential pharmaceuticals |
| Study Summary | Crocodiles thrive in unsanitary conditions, feed on rotten meat, are exposed to heavy metals and are among the very few species to endure the catastrophic Cretaceous-Tertiary extinction event, and yet they can live up to 100 years. We hypothesized that crocodiles have developed mechanisms to achieve such longevity while surviving under stressful conditions. We speculate that their microbial gut flora may produce substances contributing to their “hardiness” and “longevity”. Previously we characterized selected microbial gut bacteria colonizing the gastrointestinal tract of Crocodylus porosus (CP) using 16S rDNA sequencing. Next, bacterial conditioned media containing gut microbial metabolites were prepared. Bioassay-guided testing of selected bacterial conditioned media using LC-TIMS-QTOF MS, revealed the identity of gut microbial metabolites. Among two bacterial conditioned media, i.e., CP27 and 36, the analyses resulted in 141 highly confidently (MS/MS) identified metabolites in both samples. The pairwise comparison of the two samples indicated that 109 metabolites change significantly between them (p <0.05). Among abundant metabolites more prevalent in CP36 there were 2-Methyl-4-nitroimidazole, N-Acetyl-L-tyrosine, Acetaminophen, Trans-Ferulic acid, N, N-Dimethylformamide, Pyrocatechol, Cyclohexanone, 3, 4-Dihydrozphenylglycol, Diphenhydramine, Melatonin, Gamma –terpinene. Whereas in CP27 samples the most abundant metabolites were Carbamazepin, deoxyninosine, Cysteamine, Benzylnicotinate, 3-phenoxypropionic acid, Indole-3-carbinol, Benzaldehyde, Benzocaine, 2-Aminobenzoic acid, 3-Methylindole. Functional enrichment analysis of all identified metabolites with metabolite sets based on drug pathways showed that they were enriched for drug action of top ten pathways associating with enalapril metabolism pathway, diphenhydramine H1-Antihistamine action, enalarpil action pathway, benzocaine action pathway, mepivacaine action pathway, oxybuprocaine action pathways, nifedipine action pathway, propranolol action pathway, acetaminophen metabolism pathway, carbamazepine metabolism pathway. These findings suggest that analyses of crocodile gut bacteria may reveal potential drug leads, intensive future research is needed to realize these expectations. |
| Institute | Sharjah Institute for Medical Research |
| Last Name | Facility |
| First Name | Core |
| Address | M32, SIMR, College of Pharmacy, Health Sciences, University of Sharjah, Sharjah, UAE, Sharjah, 000, United Arab Emirates |
| tims-tof@sharjah.ac.ae | |
| Phone | +971 6 5057656 |
| Submit Date | 2022-12-22 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | d |
| Analysis Type Detail | LC-MS |
| Release Date | 2023-06-22 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Combined analysis:
| Analysis ID | AN003988 |
|---|---|
| Analysis type | MS |
| Chromatography type | Reversed phase |
| Chromatography system | Bruker Elute |
| Column | Hamilton Intensity Solo 2 C18 (100 x 2.1 mm, 1.8 µm, 90 Å) |
| MS Type | ESI |
| MS instrument type | QTOF |
| MS instrument name | Bruker timsTOF |
| Ion Mode | POSITIVE |
| Units | AU |
Chromatography:
| Chromatography ID: | CH002948 |
| Instrument Name: | Bruker Elute |
| Column Name: | Hamilton Intensity Solo 2 C18 (100 x 2.1 mm, 1.8 µm, 90 Å) |
| Column Temperature: | 35 |
| Flow Gradient: | 1%B to 99%B in 15 min |
| Flow Rate: | 250 uL/min |
| Solvent A: | 100% water; 0.1% formic acid |
| Solvent B: | 100% acetonitrile; 0.1% formic acid |
| Chromatography Type: | Reversed phase |
